Literature DB >> 11068759

Methods of purification of heat shock protein-peptide complexes for use as vaccines against cancers and infectious diseases.

P K Srivastava1, N S Jaikaria.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11068759     DOI： 10.1385/1-59259-062-4:175

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN： 1064-3745


× No keyword cloud information.
  8 in total

Review 1.  Hsp70 interactions with the p53 tumour suppressor protein.

Authors:  M Zylicz; F W King; A Wawrzynow
Journal:  EMBO J       Date:  2001-09-03       Impact factor: 11.598

2.  Autologous heat-shock protein vaccines.

Authors:  Camilo Colaco
Journal:  Hum Vaccin Immunother       Date:  2013-01-04       Impact factor: 3.452

Review 3.  Secreted heat shock protein gp96-Ig: next-generation vaccines for cancer and infectious diseases.

Authors:  Natasa Strbo; Arlene Garcia-Soto; Taylor H Schreiber; Eckhard R Podack
Journal:  Immunol Res       Date:  2013-12       Impact factor: 2.829

4.  Dendritic cells pulsed with hsp70-peptide complexes derived from human hepatocellular carcinoma induce specific anti-tumor immune responses.

Authors:  Xian-Hua Wang; Yan Qin; Mei-Hao Hu; Yong Xie
Journal:  World J Gastroenterol       Date:  2005-09-28       Impact factor: 5.742

5.  Activation of NK cells by extracellular heat shock protein 70 through induction of NKG2D ligands on dendritic cells.

Authors:  Yi Qiao; Bei Liu; Zihai Li
Journal:  Cancer Immun       Date:  2008-07-10

6.  Myeloma cell line-derived, pooled heat shock proteins as a universal vaccine for immunotherapy of multiple myeloma.

Authors:  Jianfei Qian; Sungyoul Hong; Siqing Wang; Liang Zhang; Luhong Sun; Michael Wang; Jing Yang; Larry W Kwak; Jian Hou; Qing Yi
Journal:  Blood       Date:  2009-08-04       Impact factor: 22.113

Review 7.  Challenges in the development of an autologous heat shock protein based anti-tumor vaccine.

Authors:  Dirk J Reitsma; Austin J Combest
Journal:  Hum Vaccin Immunother       Date:  2012-08-01       Impact factor: 3.452

8.  A phase I pilot study of autologous heat shock protein vaccine HSPPC-96 in patients with resected pancreatic adenocarcinoma.

Authors:  Robert G Maki; Philip O Livingston; Jonathan J Lewis; Sylvia Janetzki; David Klimstra; Diann Desantis; Pramod K Srivastava; Murray F Brennan
Journal:  Dig Dis Sci       Date:  2007-04-10       Impact factor: 3.487
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.